Connection
Marc Bonaca to Placebos
This is a "connection" page, showing publications Marc Bonaca has written about Placebos.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.180 |
|
|
|
-
Capell WH, Barnathan ES, Piazza G, Spyropoulos AC, Hsia J, Bull S, Lipardi C, Sugarmann C, Suh E, Rao JP, Hiatt WR, Bonaca MP. Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study. Am Heart J. 2021 05; 235:12-23.
Score: 0.180